Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.35 |
| ▸ | EDNRA | P25101 | 2/20 | 0.33 |
| ▸ | EDNRB | P24530 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 3/20 | 0.32 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.32 |
| ▸ | RAC2 | P15153 | 1/20 | 0.31 |
| ▸ | RAC3 | P60763 | 1/20 | 0.31 |
| ▸ | CDC42 | P60953 | 1/20 | 0.31 |
| ▸ | RAC1 | P63000 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18563210 | 0.97 | KDM4E (0.46) | KDM4EATML3MBTL1MAPK8EDNRA | |
| SCHEMBL18563267 | 0.97 | L3MBTL1 (0.49) | KDM4EATML3MBTL1MAPK8EDNRA | |
| SCHEMBL18563212 | 0.94 | L3MBTL1 (0.43) | KDM4EATML3MBTL1MAPK8EDNRA | |
| SCHEMBL18563219 | 0.94 | KDM4E (0.45) | KDM4EATML3MBTL1MAPK8EDNRA | |
| SCHEMBL18563262 | 0.93 | KDM4E (0.44) | KDM4EATML3MBTL1MAPK8EDNRA | |
| SCHEMBL18563258 | 0.90 | L3MBTL1 (0.42) | KDM4EATML3MBTL1MAPK8EDNRA | |
| SCHEMBL18563244 | 0.90 | KDM4E (0.42) | KDM4EATML3MBTL1 | |
| SCHEMBL18563232 | 0.90 | L3MBTL1 (0.42) | KDM4EATML3MBTL1MAPK8EDNRA | |
| SCHEMBL18563224 | 0.90 | KDM4E (0.39) | KDM4EATML3MBTL1MAPK8EDNRA | |
| SCHEMBL18563256 | 0.89 | KDM4E (0.41) | KDM4EATML3MBTL1AHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10361373-B2 | Condensed-cyclic compound and organic light emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-23 | — | — | US | disclosed |
| US-20170062720-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-02 | — | — | US | disclosed |
| US-20170062720-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-02 | — | — | US | disclosed |
| EP-3135673-A2 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | Samsung Display Co., Ltd. (KR) | 2017-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170062720-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LRRK2, SLC18A1, CCNT1 | KDM4E 1389/4885ATM 1227/4885L3MBTL1 377/4885 |
| US-10361373-B2 | Condensed-cyclic compound and organic light emitting device comprising the same | LRRK2, SLC18A1, CCNT1 | KDM4E 1389/4885ATM 1227/4885L3MBTL1 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.